18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study

18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study

Abstract Background Current diagnostic imaging modalities have limited ability to differentiate between malignant and benign pancreaticobiliary disease, and lack accuracy in detecting lymph node metastases. 18F-Prostate-Specific Membrane Antigen (PSMA) PET/CT is an imaging modality used for staging...

Full description

Saved in:
Bibliographic Details
Main Authors: Jisce R. Puik, Thomas T. Poels, Gerrit K. J. Hooijer, Matthijs C. F. Cysouw, Joanne Verheij, Johanna W. Wilmink, Elisa Giovannetti, Geert Kazemier, Arantza Farina Sarasqueta, Daniela E. Oprea-Lager, Rutger-Jan Swijnenburg
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cancer Imaging
Subjects:
PSMA
PET/CT
PDAC
Pancreatic cancer
Diagnosis
Online Access:https://doi.org/10.1186/s40644-025-00822-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items